July 25, 2017 01:30 PM Eastern Daylight Time
CRANBURY, N.J.--Physicians’ Education Resource (PER®) will host the 18th Annual International Lung Cancer Congress (ILCC) from July 27 to 29 at the Hyatt Regency Huntington Beach in Huntington Beach, California. The co-chairs for this congress are, David R. Gandara, M.D., division of Hematology/Oncology, director Thoracic Oncology Program, senior adviser to the director at the UC Davis Comprehensive Cancer Center, and Roy S. Herbst, M.D., Ph.D., professor of pharmacology, chief of medical oncology, associate director for translational research, Yale Cancer Center and Yale School of Medicine.
In making the announcement, Phil Talamo, president of PER®, said, “We are thrilled for the upcoming International Lung Cancer Congress, now in its 18th year. The Congress has been one of the most comprehensive and detailed lung cancer CME meetings in the world with its breadth of expert faculty. This year will be one of the most impactful ever with the tremendous amount of recent data that has become available. And we are excited to discuss all of it.”
This two-day educational event will discuss the emerging information on management of lung cancer. Additionally, the program will encompass some of the most significant topics in cancer including the changing role of biomarkers, immunotherapeutic combination strategies, management of central nervous system metastases and the role of chemotherapies and anti-angiogenic strategies. The attendees will receive an opportunity to share their personal experiences and challenges with their peers and faculty.
Gandara, M.D. added, “250 of your favorite lung cancer experts and aficionados in attendance at ILCC 2017, all focused on what is new, why it is important and how it will affect your practice.” In addition, Herbst, M.D., Ph.D. said the Congress will focus on, “updates from the experts in an immersive environment to discuss patient-centered personalized care.”
For registration and more information about the program, visit www.gotoper.com/conferences/ilc/meetings/18th-International-Lung-Cancer-Congress.
Since 1995, PER® has been the leading provider of live, online and print CME activities focusing on oncology and hematology by providing high-quality, evidence-based activities featuring leading experts who focus on the application of practice-changing advances. In 2017, PER® will develop and implement 21 historic annual legacy conferences in the Unites States and Europe, along with many world renowned online learning formats. PER® is also the publisher of the monthly peer-reviewed American Journal of Hematology/Oncology® and is accredited by the Accreditation Council for Continuing Medical Education and the California Board of Registered Nursing. PER® is part of the Cranbury, New Jersey-based Michael J. Hennessy Associates Inc. family of businesses. Learn more at www.gotoper.com and http://www.mjhassoc.com.